Patent Assignment
Reel/Frame 056729/0503
Assignment of Assignor's Interest
Recorded: 2021-06-30
Pages: 10
Assignor
MILLENNIUM PHARMACEUTICALS, INC.
Executed: 2021-05-03
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME,, CHUO-KU, OSAKA-SHI,, OSAKA, JAPAN
Covered Properties
(86)
Combination Therapy for Cancer Treatment
Application:
15/551,093 →
Publication:
US US20180235986A1
Method of Treating Primary Sclerosing Cholangitis
Application:
15/556,186 →
Publication:
US US20180051086A1
Methods for the Harvesting of Cell Cultures
Application:
15/997,158 →
Publication:
US US20180330043A1
Alginate Hydrogel Compositions
Methods of Treating Gastrointestinal Immune-Related Adverse Events in Immune Oncology Treatments
Inhibitors of E1 Activating Enzymes
Application:
16/135,380 →
Publication:
US US20190255052A1
Vedolizumab for the Treatment of Fistulizing Crohn's Disease
Method of Treating Inflammatory Bowel Disease
Combination of Proteasome Inhibitors and Anti-CD30 Antibodies
Application:
16/322,244 →
Publication:
US US20190192559A1
ATG7 Inhibitors and the Uses Thereof
Non-Adult Human Dosing of Brentuximab Vedotin
PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY
Conformal Coating of Biological Surfaces
Treatment of Gastroparesis with Triazaspiro[4.5]Decanone
Cocrystal Forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-Inden-1-Ylamino]-7H-Pyrrolo [2,3-D]Pyrimidin-7-Yl}-2-Hydroxycyclopentyl) Methyl Sulfamate, Formulations and Uses Thereof
Anti-CD38 Binding Domains
Biomarkers and Methods for Treatment with Nae Inhibitors
Application:
16/766,397 →
Publication:
US US20200377958A1
Inhibitors of E1 activating enzymes
Application:
16/855,863 →
Publication:
US US20210070798A1
Systems and Methods for Automated Tracking and Optimization of Global Manufacturing and Supply Based on Impacts of Post-Approval Changes
Application:
17/059,026 →
Publication:
US US20210209549A1
Administration of Sumo-Activating Enzyme Inhibitor and Anti-CD20 Antibodies
Nucleic Acids Encoding the C 140 Receptor
Patent:
6,297,026 →
Application:
08/486,673 →
Anti-CCR4 Antibodies and Methods of Use Therefor
Patent:
6,488,930 →
Application:
09/231,759 →
Immunoglobulin Dna Cassette Molecules, Monobody Constructs, Methods of Production, and Methods of Use Therefor
CCR9 Inhibitors and Methods of Use Thereof
PGD2 Receptor Antagonists for the Treatment of Inflammatory Diseases
CCR8 Inhibitors
Beta-Carbolines Useful for Treating Inflammatory Disease
Aryl Sulfonamides Useful as Inhibitors of Chemokine Receptor Activity
PGD2 Receptor Antagonists for the Treatment of Inflammatory Diseases
Beta-Carbolines Useful for Treating Inflammatory Disease
Substituted Pyrrolo[2,3-D]Pyrimidines as Inhibitors of E1 Activating Enzymes
PGD2 Receptor Antagonists for the Treatment of Inflammatory Diseases
CCR9 Inhibitors and Methods of Use Thereof
Bicyclic Compounds with Kinase Inhibitory Activity
Inhibitors of E1 Activating Enzymes
Heteroaryl Compounds Useful as Inhibitors of E1 Activating Enzymes
Pyridobenzazepine Compounds and Methods for Inhibiting Mitotic Progression
Process for the Synthesis of E1 Activating Enzyme Inhibitors
Derivatives of 1-Amino-2-Cyclobutylethylboronic Acid
Thiolactams and Uses Thereof
CCR9 Inhibitors and Methods of Use Thereof
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
Hydrochloride Salt of((1S,2S,4R)-4-{4-[(1S)- 2,3-Dihydro-1H-Inden-1-Ylamino]-7H- Pyrrolo[2,3-D]Pyrimidin-7-Yl}-2-Hydroxycyclopentyl)Methyl Sulfamate
D2 Antagonists, Methods of Synthesis and Methods of Use
Thiolactams and Uses Thereof
Heteroaryl Compounds Useful as Inhibitors of E1 Activating Enzymes
Thiolactams and Uses Thereof
Inhibitors of NEDD8-Activating Enzyme
Methods for the Identification, Assessment, and Treatment of Patients with Cancer Therapy
Administration of a NEDD8-Activating Enzyme Inhibitor and Hypomethylating Agent
Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
Anti-Gcc Antibody Molecules and Methods for Use of Same
Heteroaryl Compounds Useful as Inhibitors of E1 Activating Enzymes
CCR9 Inhibitors and Methods of Use Thereof
Derivatives of 1-Amino-2-Cyclobutylethylboronic Acid
D2 Antagonists, Methods of Synthesis and Methods of Use
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
Inhibitors of NEDD8-Activating Enzyme
Biomarkers of Response to Proteasome Inhibitors
Indole-Substituted Pyrrolopyrimidinyl Inhibitors of UBA6
Biomarkers and Methods to Predict Response to Inhibitors and Uses Thereof
Heteroaryl Compounds Useful as Inhibitors of E1 Activating Enzymes
Methods for the Identification, Assessment, and Treatment of Patients with Cancer Therapy
Sulfamoylating Reagents
Heteroaryls and Uses Thereof
Anti-Gcc Antibody Molecules and Methods for Use of Same
Patent:
9,273,146 →
Application:
14/634,438 →
Heteroaryl Compounds Useful as Inhibitors of Sumo Activating Enzyme
Heteroaryl Compounds Useful as Inhibitors of E1 Activating Enzymes
Hydrochloride Salt of((1S,2S,4R)-4-{4-[(1S)- 2,3-Dihydro-1H-Inden-1-Ylamino]-7H- Pyrrolo[2,3-D]Pyrimidin-7-Yl}-2-Hydroxycyclopentyl) Methyl Sulfamate
Heteroaryl Inhibitors of Sumo Activating Enzyme
Inhibitor of Breast Cancer Resistance Protein (Bcrp)
Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
Heteroaryls and Uses Thereof
Heteroaryl Compounds Useful as Inhibitors of E1 Activating Enzymes
Heteroaryls and Uses Thereof
Heteroaryl Compounds Useful as Inhibitors of Sumo Activating Enzyme
Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
Administration of Ubiquitin-Activating Enzyme Inhibitor and Radiation
Novel Crystalline Form of a Proteasome Inhibitor
Heteroaryls and Uses Thereof
Derivatives of 1-Amino-2-Cyclobutylethylboronic Acid
Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
Process for the Synthesis of E1 Activating Enzyme Inhibitors
Heteroaryl Compounds Useful as Inhibitors of Sumo Activating Enzyme
Administration of NEDD8-Activating Enzyme Inhibitor and Chemotherapeutic Agents
Heteroaryl Compounds Useful as Inhibitors of Sumo Activating Enzyme
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 6, 2017
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 043508/0849 →
Assignment of Assignor's Interest
Sep 6, 2017
From: TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 043508/0824 →
Assignment of Assignor's Interest
Sep 6, 2017
From: ABHYANKAR, BRIHAD
To: TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
Reel/Frame 043508/0738 →
Assignment of Assignor's Interest
Sep 12, 2018
From: LABOTKA, RICHARD; FERGUS, ANDREW
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 046852/0421 →
Assignment of Assignor's Interest
Nov 7, 2018
From: BRAKE, RACHAEL L.; WESTIN, ERIC H.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 047430/0432 →
Assignment of Assignor's Interest
Nov 21, 2018
From: GARLE, AMIT; GARIGAPATI, VENKATA R.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 047561/0632 →
Assignment of Assignor's Interest
Nov 21, 2018
From: HOSHINO, TETSUO
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 047561/0622 →
Assignment of Assignor's Interest
Nov 21, 2018
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 047561/0642 →
Assignment of Assignor's Interest
Jan 2, 2019
From: GASTONGUAY, MARC R.
To: METRUM RESEARCH GROUP LLC
Reel/Frame 047881/0149 →
Assignment of Assignor's Interest
Jan 2, 2019
From: METRUM RESEARCH GROUP LLC
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 047881/0154 →
Assignment of Assignor's Interest
Jan 2, 2019
From: ROSARIO, MARIA
To: MILLENIUM PHARMACEUTICALS, INC.
Reel/Frame 047881/0092 →
Assignment of Assignor's Interest
Jan 2, 2019
From: BAROCAS, MORRIS
To: TAKEDA PHARMACEUTICALS AMERICA, INC.
Reel/Frame 047881/0117 →
Assignment of Assignor's Interest
Jan 2, 2019
From: TAKEDA PHARMACEUTICALS AMERICA, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 047881/0128 →
Assignment of Assignor's Interest
Jan 2, 2019
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 047881/0135 →
Assignment of Assignor's Interest
Mar 18, 2019
From: LASCH, KAREN L.
To: TAKEDA PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 048624/0539 →
Assignment of Assignor's Interest
Mar 18, 2019
From: TAKEDA PHARMACEUTICALS INTERNATIONAL, INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 048624/0625 →
Assignment of Assignor's Interest
Apr 30, 2019
From: CHATTOPADHYAY, NIBEDITA; HUEBNER, DIRK; SYED, SAKEENA
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 049034/0614 →
Assignment of Assignor's Interest
May 20, 2019
From: FASANMADE, ADEDIGBO
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 049221/0669 →
Assignment of Assignor's Interest
Jun 21, 2019
From: GARIGAPATI, VENKAT R.; MATSUURA, TETSUYA
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 049546/0063 →
Assignment of Assignor's Interest
Jul 18, 2019
From: ROSARIO, MARIA; WYANT, TIMOTHY L.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 049792/0364 →
Assignment of Assignor's Interest
Jul 18, 2019
From: TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LTD.
Reel/Frame 049792/0454 →
Assignment of Assignor's Interest
Jul 18, 2019
From: TAKEDA PHARMACEUTICAL COMPANY, LTD.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 049792/0488 →
Assignment of Assignor's Interest
Jul 18, 2019
From: ABHYANKAR, BRIHAD
To: TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
Reel/Frame 049792/0411 →
Assignment of Assignor's Interest
Feb 14, 2020
From: ELIAS, KATHLEEN ANN; LANDES, GREGORY; SINGH, SHWETA; KORVER, WOUTER
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 051825/0798 →
Assignment of Assignor's Interest
Jun 26, 2020
From: ADHIKARI, SHARMILA; CALDERWOOD, EMILY FRANCES; ENGLAND, DYLAN BRADLEY; GOULD, ALEXANDRA E.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 053049/0184 →